301108.SHE Tongling Jieya Biologic Technology Co. Ltd.
- Market cap
- CNY 4.74B
- P/E
- 87.7x
- P/B
- 2.48x
- ROE
- 3.2%
- Dividend yield
- 0.41%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301108.SHE undervalued?
Graham numberThe Graham number of Tongling Jieya Biologic Technology Co. Ltd. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Tongling Jieya Biologic Technology Co. Ltd. fundamental analysis
No fundamental analysis for Tongling Jieya Biologic Technology Co. Ltd. yet.
Tongling Jieya Biologic Technology Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Tongling Jieya Biologic Technology Co. Ltd.
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipe products in China. The company provides dry and wet wipes, including baby wipes, wet toilet paper, personal care wipes, dry towels, antibacterial and disinfecting wipes, and home cleaning wet towel products. It also offers beauty care products, such as emollient water, lotion, cream, essence, facial masks, makeup removers, and body and hair care products, as…
Full company profileTongling Jieya Biologic Technology Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Tongling Jieya Biologic Technology Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 277M | 743M | 984M | 667M | 623M | 547M | 772M | 891M |
| Gross Profit | 101M | 266M | 323M | 210M | 184M | 107M | 196M | 198M |
| Operating Income | 74.3M | 222M | 254M | 146M | 106M | 32.4M | 101M | 103M |
| EBITDA | 92.3M | 222M | 284M | 198M | 175M | 72.7M | 140M | 64.9M |
| Net Income | 68.1M | 180M | 220M | 141M | 115M | 19.5M | 77.3M | 60.2M |
| EPS | 2.24 | 2.95 | 1.94 | 1.24 | 1.01 | 0.24 | 0.69 | 0.54 |
| Balance Sheet | ||||||||
| Total Assets | 394M | 875M | 2.05B | 2.07B | 2.15B | 2.08B | 2.33B | 2.58B |
| Total Liabilities | 130M | 433M | 359M | 288M | 290M | 254M | 446M | 668M |
| Shareholders' Equity | 264M | 442M | 1.69B | 1.78B | 1.86B | 1.83B | 1.88B | 1.91B |
| Cash & Short-term Investments | 137M | 321M | 1.42B | 1.00B | 665M | 404M | 649M | 759M |
| Cash Flow | ||||||||
| Operating Cash Flow | 107M | 188M | 200M | 299M | 83.5M | 75.1M | 99.2M | - |
| Capital Expenditure | 29.3M | 103M | 72.6M | 29.9M | 85.1M | 96.2M | 368M | 72.3M |
| Free Cash Flow | 77.5M | 84.4M | 128M | 269M | -1.54M | -21.1M | -269M | 120M |
| Ratios | ||||||||
| ROE | 25.8% | 40.7% | 13.0% | 7.9% | 6.2% | 1.1% | 4.1% | 3.2% |
| ROA | 17.3% | 20.5% | 10.7% | 6.8% | 5.4% | 0.9% | 3.3% | 2.3% |
| Net Profit Margin | 24.6% | 24.2% | 22.4% | 21.1% | 18.5% | 3.6% | 10.0% | 6.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Tongling Jieya Biologic Technology Co. Ltd. dividends
- Dividend yield
- 0.41%
- Forward dividend
- 0.27 CNY
- Payout ratio
- 25.0%
- Ex-dividend date
- Sep 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 19.3M | 0.17 | 25.0% |
| 2024 | CNY 29.2M | 0.36 | 149.8% |
| 2023 | CNY 40.6M | 0.36 | 35.2% |
| 2022 | CNY 60.9M | 0.54 | 43.2% |
| 2021 | CNY 263K | 0.00 | 0.1% |
| 2020 | CNY 3.03M | 0.05 | 1.7% |
| 2019 | CNY 30.7M | 1.01 | 45.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jul 10, 2025.
Who owns Tongling Jieya Biologic Technology Co. Ltd.
- Insiders 59.35%
- Institutions 14.65%
- Public & others 26.00%
- Shares outstanding 113M
- Free float 36.6M
Tongling Jieya Biologic Technology Co. Ltd. company profile
- Company name
- Tongling Jieya Biologic Technology Co. Ltd.
- Ticker
- 301108.SHE
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 634
- Fiscal year end
- December
- Address
- No. 528, Geology Avenue, Tongling, China, 244031
- Phone
- 86 21 5988 6288
- Website
- babywipes.com.cn
About Tongling Jieya Biologic Technology Co. Ltd.
Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipe products in China. The company provides dry and wet wipes, including baby wipes, wet toilet paper, personal care wipes, dry towels, antibacterial and disinfecting wipes, and home cleaning wet towel products. It also offers beauty care products, such as emollient water, lotion, cream, essence, facial masks, makeup removers, and body and hair care products, as well as products for children, including baby lotion, baby cream, baby oil, and baby shower gel. The company was founded in 1999 and is based in Tongling, China.
Tongling Jieya Biologic Technology Co. Ltd. management
5- Mr. Yingchuan CaiChairman of the Board & GM · born 1969
- Mr. Fanlong YangCFO, Accounting Supervisor & Director · born 1988
- Ms. Ying YeDeputy GM & Director · born 1976
- Mr. Nenghua HuDeputy GM & Board Secretary · born 1968
- Mr. Xiang-Kui ZhaiDeputy General Manager · born 1981